Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.72 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.43 |
| ▸ | YAP1 | P46937 | 1/20 | 0.43 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.43 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24234909 | 0.91 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL32668010 | 0.91 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL17839852 | 0.88 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL11127833 | 0.87 | ALDH1A1 (0.94) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL3074569 | 0.87 | — | — | |
| SCHEMBL5830059 | 0.87 | ALDH1A1 (0.83) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL5525368 | 0.86 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL11126451 | 0.84 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL8038216 | 0.84 | — | — | |
| SCHEMBL11097335 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Belyntic GmbH (DE) | 2025-11-18 | — | — | US | claimed |
| CN-114206902-B | Method for modifying peptides immobilized on a solid support by means of a traceless reducing cleavable linker molecule | 格瑞罗斯普罗泰恩科技公司 | 2025-02-21 | — | — | CN | claimed |
| US-20220363713-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-11-17 | — | — | US | claimed |
| CN-114206902-A | Method for modifying a peptide immobilized on a solid support by means of a traceless reductively cleavable linker molecule | 贝兰迪克有限责任公司 | 2022-03-18 | — | — | CN | claimed |
| CN-114058173-A | Process and composition for producing flexible polyurethane foams | 赢创运营有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Belyntic GmbH (DE) | 2025-11-18 | — | — | US | disclosed |
| CN-114206902-B | Method for modifying peptides immobilized on a solid support by means of a traceless reducing cleavable linker molecule | 格瑞罗斯普罗泰恩科技公司 | 2025-02-21 | — | — | CN | disclosed |
| EP-4010352-B1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | GYROS PROTEIN TECH AB (SE) | 2023-10-18 | — | — | EP | disclosed |
| US-11788081-B2 | Protein macrocyclization | STICHTING VU (NL) | 2023-10-17 | — | — | US | disclosed |
| US-20220363713-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-11-17 | — | — | US | disclosed |
| EP-3883865-B1 | SEAL OF A PORTION CAPSULE | GCS GERMAN CAPSULE SOLUTION GMBH (DE) | 2022-11-09 | — | — | EP | disclosed |
| EP-4010352-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-06-15 | — | — | EP | disclosed |
| EP-1396514-A1 | Anti-bacterial polymer and method for the preparation thereof, anti-bacterial polymer film and method for the preparation thereof, and article having such a film on the surface thereof | ULVAC, INC. (JP) | 2004-03-10 | — | — | EP | disclosed |
| WO-2003014192-A1 | QUATERNARY POLYAMIDOAMINES, THE PRODUCTION THEREOF, CORRESPONDING AGENTS AND THE USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-20 | — | — | WO | disclosed |
| EP-1184377-A1 | Hepatobiliary magnetic resonance contrast agents | BRACCO International B.V. (NL) | 2002-03-06 | — | — | EP | disclosed |
| WO-1995009161-A1 | HEPATOBILIARY MAGNETIC RESONANCE CONTRAST AGENTS | BRACCO INTERNATIONAL B.V. (NL) | 1995-04-06 | — | — | WO | disclosed |
| US-5358704-A | Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents | BRISTOL-MYERS SQUIBB (US) | 1994-10-25 | — | — | US | disclosed |
| US-4362528-A | OXIDATION COLOR DYE,CATIONIC POLYMER TO IMPROVE FEEL,SHAMPOO WITH ANIONIC DETERGENT | SOCIETE ANONYME DITE: L'OREAL (FR) | 1982-12-07 | — | — | US | disclosed |
| US-4314807-A | CATIONIC POLYMER, ANIONIC SURFACTANT SHAMPOO | L'OREAL (FR) | 1982-02-09 | — | — | US | disclosed |
| US-4013787-A | CATIONIC POLYMERS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363713-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | PTMS, VIP, HM13 | ALDH1A1 1890/4885SMN1; SMN2 3665/4885TEAD1 2067/4885 |
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | PTMS, VIP, HM13 | ALDH1A1 2067/4885SMN1; SMN2 3924/4885TEAD1 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.